These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26241537)

  • 21. Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis.
    Flourié B; Hagège H; Tucat G; Maetz D; Hébuterne X; Kuyvenhoven JP; Tan TG; Pierik MJ; Masclee AA; Dewit O; Probert CS; Aoucheta D;
    Aliment Pharmacol Ther; 2013 Apr; 37(8):767-75. PubMed ID: 23451806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Budesonide foam as a new therapeutic principle in distal ulcerative colitis in comparison with mesalazine enema. An open, controlled, randomized and prospective multicenter pilot study].
    Rufle W; Frühmorgen P; Huber W; Kimmig JM
    Z Gastroenterol; 2000 Apr; 38(4):287-93. PubMed ID: 10820860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral prolonged release beclomethasone dipropionate and prednisone in the treatment of active ulcerative colitis: results from a double-blind, randomized, parallel group study.
    Van Assche G; Manguso F; Zibellini M; Cabriada Nuño JL; Goldis A; Tkachenko E; Varoli G; Kleczkowski D; Annese V; D'Heygere F; Balzano A;
    Am J Gastroenterol; 2015 May; 110(5):708-15. PubMed ID: 25869389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis--additional results from two controlled studies.
    Sandborn WJ; Hanauer S; Lichtenstein GR; Safdi M; Edeline M; Scott Harris M
    Aliment Pharmacol Ther; 2011 Oct; 34(7):747-56. PubMed ID: 21848857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A practical guide to the management of distal ulcerative colitis.
    Ardizzone S; Bianchi Porro G
    Drugs; 1998 Apr; 55(4):519-42. PubMed ID: 9561342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left-sided ulcerative colitis: a randomized, double-blind, active-controlled trial.
    Miner PB; Wedel MK; Xia S; Baker BF
    Aliment Pharmacol Ther; 2006 May; 23(10):1403-13. PubMed ID: 16669955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined oral sodium butyrate and mesalazine treatment compared to oral mesalazine alone in ulcerative colitis: randomized, double-blind, placebo-controlled pilot study.
    Vernia P; Monteleone G; Grandinetti G; Villotti G; Di Giulio E; Frieri G; Marcheggiano A; Pallone F; Caprilli R; Torsoli A
    Dig Dis Sci; 2000 May; 45(5):976-81. PubMed ID: 10795763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis.
    Cortot A; Maetz D; Degoutte E; Delette O; Meunier P; Tan G; Cazals JB; Dewit O; Hebuterne X; Beorchia S; Grunberg B; Leprince E; D'Haens G; Forestier S; Idier I; Lémann M
    Am J Gastroenterol; 2008 Dec; 103(12):3106-14. PubMed ID: 19086960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral beclometasone dipropionate in the treatment of extensive and left-sided active ulcerative colitis: a multicentre randomised study.
    Campieri M; Adamo S; Valpiani D; D'Arienzo A; D'Albasio G; Pitzalis M; Cesari P; Casetti T; Castiglione GN; Rizzello F; Manguso F; Varoli G; Gionchetti P
    Aliment Pharmacol Ther; 2003 Jun; 17(12):1471-80. PubMed ID: 12823149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesalazine Modified-Release Tablet in the Treatment of Ulcerative Colitis in the Active Phase: A Chinese, Multicenter, Single-Blind, Randomized Controlled Study.
    Sun J; Yuan Y
    Adv Ther; 2016 Mar; 33(3):400-9. PubMed ID: 26898569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesalazine granules are superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis - a pooled analysis.
    Leifeld L; Pfützer R; Morgenstern J; Gibson PR; Marakhouski Y; Greinwald R; Mueller R; Kruis W
    Aliment Pharmacol Ther; 2011 Nov; 34(9):1115-22. PubMed ID: 21923715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: a prospective, multicenter study.
    Meucci G; Fasoli R; Saibeni S; Valpiani D; Gullotta R; Colombo E; D'Incà R; Terpin M; Lombardi G;
    Inflamm Bowel Dis; 2012 Jun; 18(6):1006-10. PubMed ID: 21830282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined diosmectite and mesalazine treatment for mild-to-moderate ulcerative colitis: a randomized, placebo-controlled study.
    Jiang XL; Wang HH; Cui HF
    Med Sci Monit; 2015 Jan; 21():163-70. PubMed ID: 25582578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of sodium hyaluronate (IBD98E) in the induction of clinical and endoscopic remission in subjects with distal ulcerative colitis.
    Fiorino G; Gilardi D; Naccarato P; Sociale OR; Danese S
    Dig Liver Dis; 2014 Apr; 46(4):330-4. PubMed ID: 24462118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study.
    Rizzello F; Gionchetti P; D'Arienzo A; Manguso F; Di Matteo G; Annese V; Valpiani D; Casetti T; Adamo S; Prada A; Castiglione GN; Varoli G; Campieri M
    Aliment Pharmacol Ther; 2002 Jun; 16(6):1109-16. PubMed ID: 12030952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of oral beclometasone dipropionate in the treatment of active ulcerative colitis in clinical practice: the RECLICU Study.
    Nunes T; Barreiro-de Acosta M; Nos P; Marin-Jiménez I; Bermejo F; Ceballos D; Iglesias E; Gomez-Senent S; Torres Y; Ponferrada A; Arevalo JA; Hernandez V; Calvet X; Ginard D; Monfort D; Chaparro M; Manceñido N; Domínguez-Antonaya M; Villalón C; Perez-Calle JL; Muñoz C; Nuñez H; Carpio D; Aramendiz R; Bujanda L; Estrada-Oncins S; Hermida C; Barrio J; Casis MB; Dueñas-Sadornil MC; Fernández L; Calvo-Cenizo MM; Botella B; de Francisco R; Ayala E; Sans M;
    J Crohns Colitis; 2010 Dec; 4(6):629-36. PubMed ID: 21122572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The topical therapy of ulcerative colitis. A multicenter study with beclomethasone dipropionate foam].
    Arcidiacono R; Zanasi G; Pirone Z; Borzio M; Borzio F; Milano G; Cestari L; Ravelli P; Terraroli C; de Franchis R; Vecchi M; Galeone M; Toti GL; Cacioli D; Luminari L; Giannelli C; Gioiemi A; Russello D; Di Blasi M; Di Stefano A; Russo A; Aprile G; Biraghi M
    Minerva Chir; 1999 Sep; 54(9):635-44. PubMed ID: 10549210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Kangfuxin Liquid enema combined with mesalazine on gestational outcomes and quality of life in child-bearing female with active ulcerative colitis: A protocol for randomized, double-blind, controlled trial.
    Wang T; Lu H; Li F; Zhang Q
    Medicine (Baltimore); 2021 Feb; 100(5):e23915. PubMed ID: 33592844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life improvements attributed to combination therapy with oral and topical mesalazine in mild-to-moderately active ulcerative colitis.
    Connolly MP; Poole CD; Currie CJ; Marteau P; Nielsen SK
    Digestion; 2009; 80(4):241-6. PubMed ID: 19828955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral beclomethasone dipropionate as an alternative to systemic steroids in mild to moderate ulcerative colitis not responding to aminosalicylates.
    Papi C; Aratari A; Moretti A; Mangone M; Margagnoni G; Koch M; Capurso L
    Dig Dis Sci; 2010 Jul; 55(7):2002-7. PubMed ID: 19937467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.